[14C]Aminopyrine breath test in chronic liver disease: preliminary diagnostic implications.
The [14C]aminopyrine breath test (APBT) score, an estimate of hepatic mixed-oxidase function, was evaluated in 21 consecutive patients wih active nonalcoholic chronic liver diseases. Ten had primary biliary cirrhosis (PBC) and 11 had chronic active hepatitis (CAH). The APBT score was normal or elevated in patients with PBC (P less than 0.001), and lower than normal in CAH patients (P less than 0.01); 10.5 +/- 1.6 and 3.5 +/- 1.86, respectively, vs control 7.65 +/- 1.15 (mean +/- SD). The 11 patients with CAH included two middle-aged women who displayed ambiguous severe intrahepatic cholestasis. There was no overlap between the APBT scores of the 10 PBC and 11 CAH patients. These initial data suggest that the APBT may be helpful in the differentiation of PBC and CAH, including misleading cholestatic forms of CAH.
D000328:Adult; D000368:Aged; D000632:Aminopyrine; D001944:Breath Tests / Q000379:methods*; D002250:Carbon Radioisotopes; D002779:Cholestasis / Q000378:metabolism; D002908:Chronic Disease; D005069:Evaluation Studies as Topic; D005260:Female; D006505:Hepatitis / Q000378:metabolism; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000378:metabolism; D008111:Liver Function Tests / Q000379:methods*; D008297:Male; D008875:Middle Aged
D002250:Carbon Radioisotopes; D000632:Aminopyrine